TargetingOne Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2015

Location

Beijing China

Primary Industry

Biotechnology

About

Founded in 2015 and based in Beijing, China, TargetingOne is a biotech company that focuses on the development of micro-droplet digital PCR systems and in vitro diagnostic reagents. It has service centres in Hunan, Fujian, Guangdong, Henan, Liaoning, and Shanghai. The company acquired certifications such as ISO9001 and ISO14001. It has obtained more than 100 patents. In April 2024, the company raised CNY 100 million in strategic investment from new investor State-Owned Capital Operation and Management Centre of Beijing. The company mainly provides equipment, reagents, and consumables. The equipment includes digital PCR platforms, nucleic acid extraction instruments, and PCR amplification instrument. Reagents include human EGFR (Epidermal Growth Factor Receptor) gene mutation detection and virus rapid extraction. Consumables include disposable virus sampling tubes and digital PCR consumables. The company's products are used in fields such as tumours, genetic diseases and infectious diseases. The company generates revenue by providing droplet digital PCR (Polymerase Chain Reaction), droplet technology platform, non-invasive prenatal testing, and liquid biopsy. The company will use the strategic investment to accelerate the company's clinical registration of digital PCR and molecular POCT series reagent products.

Current Investors

Beijing Hetang Investment Management, Shanghai Qingyan Investment Management, Lilly Asia Ventures

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Bioinformatics, Oncology/Cancer Treatment, Diagnostic Equipment, Medical Equipment Distributors

Website

www.targetingone.com

Verticals

HealthTech, Manufacturing

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.